Millipede AspiRation for Revascularization in Stroke (MARRS) Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 235 participants.

Also called NCT05714501

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 235 participants (enrolled count) (from the registry)
Sponsor
Perfuze (from the registry)
Registry
  • NCT NCT05714501
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, France, Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05714501. Allocation not applicable; no masking; primary purpose treatment. Start 2023-10-09 (actual); primary completion 2025-03-08 (actual). Results posted on 2026-07-10.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Millipede AspiRation for Revascularization in Stroke (MARRS) Study
Acronym
MARRS
Condition
Acute Ischemic Stroke
Intervention (Device)
Millipede System
Lead sponsor
Perfuze (class: industry)

Record details

Record id
cardio:ct-nct05714501
Content hash
92650cf94525811979101395b049659ea077f954ac42f12a28063bd764178c5f